Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.

Eitemau Tebyg

• Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.
  gan: Nagata, K, et al.
  Cyhoeddwyd: (1993)
• Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease.
  gan: Nagata, K, et al.
  Cyhoeddwyd: (1995)
• Inhibitory Activities of Lansoprazole against Respiration in Helicobacter pylori
  gan: Nagata, Kumiko, et al.
  Cyhoeddwyd: (2001)
• Growth inhibition of Ureaplasma urealyticum by the proton pump inhibitor lansoprazole: direct attribution to inhibition by lansoprazole of urease activity and urea-induced ATP synthesis in U. urealyticum.
  gan: Nagata, K, et al.
  Cyhoeddwyd: (1995)
• Helicobacter pylori, proton pump inhibitors and gastroesophageal reflux disease.
  gan: Kuipers, E. J., et al.
  Cyhoeddwyd: (1999)